{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:39:30Z","timestamp":1793176770210,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005961","name":"Universidad Nacional de Cuyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020302","name":"National University of Cuyo Office of Research International and Postgraduate Studies","doi-asserted-by":"publisher","award":["06\/80020240100626UN\/2025"],"award-info":[{"award-number":["06\/80020240100626UN\/2025"]}],"id":[{"id":"10.13039\/501100020302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacl.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:29:51Z","timestamp":1787390991000},"page":"2237-2245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated lipoprotein(a) and prevalent cardiovascular disease burden in treated hypertension"],"prefix":"10.1016","volume":"20","author":[{"given":"Nicol\u00e1s F.","family":"Renna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Arrupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-1515","authenticated-orcid":false,"given":"Juan Bautista","family":"Soumoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5385-5275","authenticated-orcid":false,"given":"Santiago","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2557-6367","authenticated-orcid":false,"given":"Federico","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6222-4312","authenticated-orcid":false,"given":"Ezequiel","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Lavalle-Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1690-6597","authenticated-orcid":false,"given":"Gustavo","family":"Lavenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-1109","authenticated-orcid":false,"given":"Mar\u00eda Gabriela","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-055X","authenticated-orcid":false,"given":"Laura","family":"Schreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-8725","authenticated-orcid":false,"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.08.008_bib1","series-title":"Global Report on Hypertension: The Race Against a Silent Killer","year":"2023"},{"key":"10.1016\/j.jacl.2026.08.008_bib2","first-page":"1827","article-title":"The global epidemiology of hypertension","volume":"395","author":"Mills","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.08.008_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.08.008_bib4","first-page":"1625","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jacl.2026.08.008_bib5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"38","key":"10.1016\/j.jacl.2026.08.008_bib6","first-page":"4173","article-title":"2024 ESC guidelines on cardiovascular disease prevention","volume":"45","author":"Visseren","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.008_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.111.187021","article-title":"Vascular remodeling in hypertension","volume":"59","author":"Schiffrin","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacl.2026.08.008_bib8","first-page":"656","article-title":"Vascular dysfunction in hypertension","volume":"15","author":"Touyz","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib9","first-page":"196","article-title":"Lipoprotein(a): biology and pathophysiology","volume":"10","author":"Boffa","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a)","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with lipoprotein(a) concentration and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.08.008_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2026.08.008_bib13","first-page":"1154","article-title":"Elevated lipoprotein(a) and risk of myocardial infarction","volume":"53","author":"Kamstrup","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib14","first-page":"1345","article-title":"Lipoprotein(a) as a cardiovascular risk factor","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.jacl.2026.08.008_bib15","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.03.003","article-title":"The dedicated \"Lp(a) clinic\": a concept whose time has arrived?","volume":"300","author":"Tsimikas","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2026.08.008_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hipert.2024.07.005","article-title":"On behalf of the GAELp(a) investigators. Design and rationale of the Argentine Group for the study of lipoprotein(a)","volume":"42","author":"Corral","year":"2025","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.jacl.2026.08.008_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120546","article-title":"Lipoprotein(a) in Argentina: a multicenter study on prevalence and clinical outcomes","volume":"411","author":"Corral","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.008_bib19","first-page":"2009","article-title":"Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor","volume":"104","author":"Caplice","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.008_bib20","first-page":"2214","article-title":"Lipoprotein(a) as an inhibitor of fibrinolysis","volume":"24","author":"Boffa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jacl.2026.08.008_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated lipoprotein(a) and risk of ischemic stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2026.08.008_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.122.20189","article-title":"Association of lipoprotein(a) and hypertension in primary prevention of cardiovascular disease: the MESA","volume":"80","author":"Rikhi","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacl.2026.08.008_bib23","first-page":"122","article-title":"Lipoprotein(a) measurement issues","volume":"62","author":"Marcovina","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.08.008_bib24","first-page":"3925","article-title":"Lipoprotein(a) measurement, units, and interpretation","volume":"43","author":"Nordestgaard","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.008_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2026.08.008_bib26","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.jacl.2026.08.008_bib27","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2026.08.008_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MED.0000000000000237","article-title":"Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk","volume":"23","author":"Tsimikas","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacl.2026.08.008_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwag037","article-title":"The additive prognostic value of lipoprotein(a) for all-cause and cardiovascular mortality across the traditional cardiovascular risk continuum: analysis from NHANES III (1988-1994) with follow-up to 2019","author":"Al-Jarshawi","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.008_bib30","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.3390\/ijms241713363","article-title":"Lipoprotein(a): just an innocent bystander in arterial hypertension?","volume":"24","author":"Brosolo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jacl.2026.08.008_bib31","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2026.08.008_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41440-025-02427-1","article-title":"Intentional and unintentional non-adherence in hypertension: psychometric validation, adherence\u2013complexity phenotyping and causal mediation analysis from the VATAHTA study","volume":"49","author":"Renna","year":"2026","journal-title":"Hypertens Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:27:05Z","timestamp":1793176025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1933287426004903"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.008","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated lipoprotein(a) and prevalent cardiovascular disease burden in treated hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}